Prognostic value of prostate-specific antigen in advanced prostate cancer treated with androgen deprivation therapy and abiraterone
OBJECTIVE: Prostate-specific antigen (PSA) has been a cornerstone in diagnosing and monitoring prostate cancer. With the advent of advanced hormonal therapies, such as the combination of androgen deprivation therapy (ADT) and abiraterone acetate plus prednisone (AAP+ADT), understanding PSA's pr...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Verduci Editore
2024-11-01
|
| Series: | World Cancer Research Journal |
| Subjects: | |
| Online Access: | https://www.wcrj.net/wp-content/uploads/sites/5/2024/11/e2850.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|